Nine NJ companies earned spots on Deloitte’s 2025 Fast 500 list, highlighting exceptional growth across software, fintech and ...
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback